0001104659-20-072141.txt : 20200610 0001104659-20-072141.hdr.sgml : 20200610 20200610200125 ACCESSION NUMBER: 0001104659-20-072141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200608 FILED AS OF DATE: 20200610 DATE AS OF CHANGE: 20200610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dukes Iain D. CENTRAL INDEX KEY: 0001681955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36860 FILM NUMBER: 20955898 MAIL ADDRESS: STREET 1: 112 W. 34TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IOVANCE BIOTHERAPEUTICS, INC. CENTRAL INDEX KEY: 0001425205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 753254381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 999 SKYWAY ROAD STREET 2: SUITE 150 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 6502607120 MAIL ADDRESS: STREET 1: 999 SKYWAY ROAD STREET 2: SUITE 150 CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Lion Biotechnologies, Inc. DATE OF NAME CHANGE: 20131015 FORMER COMPANY: FORMER CONFORMED NAME: Genesis Biopharma, Inc DATE OF NAME CHANGE: 20100319 FORMER COMPANY: FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP DATE OF NAME CHANGE: 20080128 4 1 tm2022303d5_4.xml OWNERSHIP DOCUMENT X0306 4 2020-06-08 0 0001425205 IOVANCE BIOTHERAPEUTICS, INC. IOVA 0001681955 Dukes Iain D. C/O IOVANCE BIOTHERAPEUTICS, INC. 999 SKYWAY ROAD, SUITE 150 SAN CARLOS CA 94070 1 0 0 0 Stock Option (right to buy) 32.17 2020-06-08 4 A 0 70000 0 A 2030-06-07 Common Stock 70000 70000 D These options are exercisable in four equal quarterly installments of 17,500 each following the date of grant, such that the options will be fully vested and exercisable on June 8, 2021. /s/ Iain Dukes 2020-06-10